Physician profile
Thomas T Easter
NPI 1922038595
$6,885.41
in general payments reported to CMS, 2019-2025
37 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,657 · 2020: $710 · 2021: $979 · 2022: $972 · 2023: $553 · 2024: $1,602 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672 · Travel and Lodging: $883 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.79 |
| Travel and Lodging | $883.21 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,059.03 | 2022-2024 | Solyx Sis System |
| Medtronic, INC. | $971.02 | 2021-2025 | Interstim |
| Intuitive Surgical, INC. | $774.53 | 2019 | |
| Abbvie INC. | $704.57 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Medtronic USA, INC. | $517.96 | 2019-2020 | |
| Coloplast Corp | $442.12 | 2019-2024 | |
| Astellas Pharma US INC | $434.01 | 2019-2023 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $365.49 | 2021-2025 | |
| Therapeuticsmd, INC. | $313.24 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $179.84 | 2023-2025 | Myfembree, Gemtesa |
| Minerva Surgical, INC | $140.66 | 2019-2025 | |
| Pfizer INC. | $125.43 | 2019-2024 | |
| Baxter Healthcare | $123.80 | 2022 | |
| Millicent US INC | $82.88 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Biohaven Pharmaceuticals, INC. | $76.99 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $64.68 | 2022-2023 | Balcoltra |
| Myovant Sciences INC. | $61.82 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $61.03 | 2019 | |
| Allergan, INC. | $58.65 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $45.08 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $40.99 | 2019 | |
| Hologic Sales and Service, LLC | $39.79 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $30.24 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $24.94 | 2019 | |
| Channel Medsystems, INC. | $23.80 | 2021-2022 | |
| Agile Therapeutics, INC. | $23.52 | 2022 | |
| Coopersurgical, INC. | $19.49 | 2019 | |
| Cosette Pharmaceuticals INC. | $19.13 | 2024 | Vyleesi |
| Duchesnay USA Incorporated | $18.75 | 2019 | |
| Exeltis, USA INC. | $15.37 | 2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $15.20 | 2020 | |
| Meditrina | $11.36 | 2022 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Easter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.